TRIPS Waiver

Publish Date
Letters
C4IP Letter to President Biden RE: Covid-19 IP Waiver Proposal
Council for Innovation Promotion Statement on ITC TRIPS Waiver Report
Yesterday, the United States International Trade Commission published its report on a possible TRIPS waiver expansion. Frank Cullen, executive director of the...
Prizes in place of Rx patents not the cure needed

A recent bipartisan request for funding of a study on replacing U.S. drug patents with cash prizes is just one more symptom...

BioWorld
C4IP Report Urges Pro-IP Rights Agenda to Counteract U.S. Innovation Stagnation

On July 11, the Council for Innovation Promotion (C4IP) released a policy report advocating for a pro-innovation legislative and administrative agenda to...

IPWatchdog
The Biden administration is endangering intellectual property rights

Waiving IP protections will do nothing to help patients when there is no longer a health emergency.

...
Dallas Morning News
An Expanded TRIPS Waiver is Unnecessary

Claim: On March 29, the International Trade Commission held a hearing on the World Trade Organization’s (WTO) proposed suspension of Covid-19 therapeutic...

Public Comments
C4IP Written Submission for Inv. No. 332-596
WHO pushes for more access to COVID-19 drugs
BioWorld
Public Comments
C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
IPWatchdog
WTO divided over expanding COVID-19 IP waiver
BioWorld
USTR: Don’t let opposition to TRIPS waiver expansion stop here

Today, the Office of the U.S. Trade Representative urged the World Trade Organization to postpone making a decision on expanding the TRIPS...

Resources:

Resources:

C4IP Letter to President Biden RE: Covid-19 IP Waiver Proposal,

12/04/2023

Press Releases:

Press Releases:

Council for Innovation Promotion Statement on ITC TRIPS Waiver Report,

10/18/2023

News:

News:

Prizes in place of Rx patents not the cure needed,

08/14/2023

News:

News:

C4IP Report Urges Pro-IP Rights Agenda to Counteract U.S. Innovation Stagnation,

07/11/2023

Op-Eds:

Op-Eds:

The Biden administration is endangering intellectual property rights,

06/20/2023

Fact Checks:

Blog, Fact Checks:

An Expanded TRIPS Waiver is Unnecessary,

05/03/2023

Resources:

Resources:

C4IP Written Submission for Inv. No. 332-596,

04/26/2023

News:

News:

WHO pushes for more access to COVID-19 drugs,

04/11/2023

Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

News:

News:

Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing,

03/29/2023

News:

News:

WTO divided over expanding COVID-19 IP waiver,

12/16/2022

Blog:

Blog:

USTR: Don’t let opposition to TRIPS waiver expansion stop here,

12/06/2022

Scroll to Top